Annette M. Bianchi
Director/Board Member at TargeGen, Inc.
Profile
Annette M.
Bianchi is currently a Director at TargeGen, Inc. and a Senior Advisor at UPMC Enterprises.
She previously held Director positions at Universal Hospital Systems, Inc. and Gilead Connecticut, Inc. She was also a Managing Director at Pacific Venture Group from 1999 to 2003, a Director at Neuraltus Pharmaceuticals, Inc., an Associate at Burr, Egan, Deleage & Co. from 1985 to 1991, a General Partner at Weiss Peck & Greer Venture Partners, and a Strategic Advisor at VantagePoint Management, Inc. Ms. Bianchi received her undergraduate and graduate degrees from the University of Pennsylvania and her MBA from The Wharton School of the University of Pennsylvania.
Annette M. Bianchi active positions
| Companies | Position | Start |
|---|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Director/Board Member | - |
UPMC Enterprises
 UPMC Enterprises Investment ManagersFinance UPMC Enterprises (UPMC Enterprises) is a venture capital subsidiary of University of Pittsburgh Medical Center founded in 2014. The firm is headquartered in Pittsburgh, Pennsylvania. | Consultant / Advisor | - |
Former positions of Annette M. Bianchi
| Companies | Position | End |
|---|---|---|
Universal Hospital Systems, Inc.
 Universal Hospital Systems, Inc. Information Technology ServicesTechnology Services Universal Hospital Systems, Inc. provides information technology services to the healthcare industry. It specializes in command and control systems that manage patient logistics, data, scheduled appointments, and orders from existing information technology systems. The company was founded by Donald Rosenthal and Tony Lazar in 2004 and is headquartered in Menlo Park, CA. | Director/Board Member | - |
| Weiss Peck & Greer Venture Partners | Corporate Officer/Principal | - |
Neuraltus Pharmaceuticals, Inc.
 Neuraltus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neuraltus Pharmaceuticals, Inc. develops and commercializes molecule therapeutics. It engages in the development of therapeutics to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease as well as inherited metaboloic disorders such as Fabry's disease and Gaucher's disease which also result in neuronal cell death. The company was founded by Michael McGrath, Edgar G. Engleman, and Ari Azhir in 2004 and is headquartered in San Bruno, CA. | Director/Board Member | - |
Pacific Venture Group
 Pacific Venture Group Investment ManagersFinance Pacific Venture Group (PVG) is a venture capital firm founded in 1995. The firm is headquartered in Encino, California. | Corporate Officer/Principal | 31/12/2003 |
| Burr, Egan, Deleage & Co. | Corporate Officer/Principal | 01/01/1991 |
Training of Annette M. Bianchi
| University of Pennsylvania | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
| Burr, Egan, Deleage & Co. | Finance |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Health Technology |
Universal Hospital Systems, Inc.
Universal Hospital Systems, Inc. Information Technology ServicesTechnology Services Universal Hospital Systems, Inc. provides information technology services to the healthcare industry. It specializes in command and control systems that manage patient logistics, data, scheduled appointments, and orders from existing information technology systems. The company was founded by Donald Rosenthal and Tony Lazar in 2004 and is headquartered in Menlo Park, CA. | Technology Services |
| Weiss Peck & Greer Venture Partners | |
VantagePoint Management, Inc.
 VantagePoint Management, Inc. Investment ManagersFinance VantagePoint Management, Inc. (VantagePoint) is a venture capital firm founded in 1996 by Alan Edward Salzman, James D. Marver. The firm is headquartered in Santa Barbara, California with additional office in Beijing, China. | Finance |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Pacific Venture Group
Pacific Venture Group Investment ManagersFinance Pacific Venture Group (PVG) is a venture capital firm founded in 1995. The firm is headquartered in Encino, California. | Finance |
Neuraltus Pharmaceuticals, Inc.
Neuraltus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neuraltus Pharmaceuticals, Inc. develops and commercializes molecule therapeutics. It engages in the development of therapeutics to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease as well as inherited metaboloic disorders such as Fabry's disease and Gaucher's disease which also result in neuronal cell death. The company was founded by Michael McGrath, Edgar G. Engleman, and Ari Azhir in 2004 and is headquartered in San Bruno, CA. | Health Technology |
UPMC Enterprises
UPMC Enterprises Investment ManagersFinance UPMC Enterprises (UPMC Enterprises) is a venture capital subsidiary of University of Pittsburgh Medical Center founded in 2014. The firm is headquartered in Pittsburgh, Pennsylvania. | Finance |
- Stock Market
- Insiders
- Annette M. Bianchi
